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Abstract
Objective—To evaluate maternal glucose levels during pregnancy as a predictor of adverse
perinatal outcomes in Dar es Salaam, Tanzania.
Methods—Random blood glucose measurements were analyzed from 3833 pregnant women
enrolled in a randomized trial to assess the impact of multivitamins on pregnancy outcomes in Dar
es Salaam between August 2001 and July 2004. Information on maternal and neonatal morbidity
was recorded at monthly study visits, delivery, and 6 weeks postpartum. Generalized estimating
equations specified with a binomial distribution and log-link function were used to determine the
relationship between elevated glucose (>7.8 mmol/L) and pregnancy outcomes.
Results—In total, 25 women had elevated glucose (0.7%). Hyperglycemia was associated with
an increased risk of delivery before 37 weeks [relative risk (RR), 2.11; 95% confidence interval
[CI], 1.07–4.13; P=0.03), delivery before 34 weeks (RR, 4.15; 95% CI, 1.43–12.03, P=0.009),
incident gestational hypertension (RR, 2.90; 95% CI, 1.24–6.76; P=0.01), low birth weight (RR,
2.87; 95% CI, 1.18–6.99; P=0.02), reduced newborn head circumference (mean difference, –1.53;
95% CI, –2.51 to –0.62; P=0.001), and stillbirth (RR, 3.38; 95% CI, 1.13–10.08; P=0.03).
Conclusion—Maternal hyperglycemia is uncommon among pregnant Tanzanian women, but
nonetheless seems to increase the risk of several adverse perinatal outcomes.
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1. Introduction
Both gestational and pre-gestational diabetes have well-known deleterious consequences for
mothers and neonates, including pregnancy-induced hypertension [1,2], stillbirth [1–4],
perinatal death [1,4–6], cesarean delivery [5,7], preterm delivery [1,5–8], high and low birth
weight [1,5,7], and both large-for-gestational age and small-for-gestational age (SGA)
outcomes [6,8]. Considerable evidence also shows that milder hyperglycemia as an
antecedent to overt diabetes can lead to adverse pregnancy outcomes [3,7,9–11].
The management of diabetic pregnancies may be a growing concern in sub-Saharan Africa,
where diabetes has received comparatively little attention. Estimates of the prevalence of
gestational diabetes in this region are scarce and have varied from 0% to 13.9% [1,11–13].
Impaired glucose tolerance, a precursor to diabetes, has been reported as 0% among
pregnant women in Tanzania [14,15] and 7.3% among those in South Africa [16].
Predictions indicate that, between 2010 and 2030, sub-Saharan Africa will experience the
largest percentage increase in diabetes of any region [17]. The prevalence of diabetes among
adults in sub-Saharan Africa is expected to increase from 3.4% to 4.7% during this time,
which will translate to 11.8 million new cases. As a result, increasing numbers of women in
this region will enter pregnancy with abnormal glucose regulation or will experience its
onset during gestation and subsequently face a substantial risk of pregnancy complications.
The aim of the present study was to examine the effect of plasma glucose levels in
pregnancy on adverse perinatal outcomes within a cohort of women who were previously
enrolled in a randomized controlled trial of daily multivitamin supplementation (vitamins B,
C, and E) versus placebo in Dar es Salaam, Tanzania, [18].
2. Materials and methods
The present study retrospectively analyzed data from pregnant women who were enrolled in
a double-blind, randomized, placebo-controlled trial at participating prenatal clinics in Dar
es Salaam, Tanzania, between August 1, 2001, and July 31, 2004 [18]. Ethics approval for
the trial was obtained from the institutional review boards of Muhimbilli University of
Health and Allied Sciences in Dar es Salaam, Tanzania, and Harvard School of Public
Health in Boston, MA, USA. Written informed consent was obtained from all women.
Women eligible for the original trial were HIV-negative, had a pregnancy of 12–27 weeks of
gestation, and were planning to stay in Dar es Salaam for at least 1 year after delivery. The
present analysis included only women who had available glucose measurements (supply
limitations precluded the measurement of glucose levels for every trial participant).
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Glucose was measured in plasma drawn from participants at regularly scheduled study visits
to prenatal clinics. Most (90%) samples were obtained between 22–34 weeks of gestation.
Glucose testing was performed with the Roche Hitachi 911 chemistry analyzer (Roche
Diagnostics, Indianapolis, IN, USA).
Individuals with abnormal glucose levels were referred for treatment as per standard of care.
Because only random plasma glucose levels were available, it was not possible to follow
conventional guidelines for the diagnosis of gestational diabetes or impaired glucose
tolerance. Instead, glucose levels exceeding 7.8 mmol/L (140 mg/dL) were considered to be
elevated. This cutoff value represents the typical upper threshold for peak postprandial
glucose during pregnancy [19]. The follow-up period for the present analysis began at the
time of glucose measurement and ended at 6 weeks postpartum.
Information on sociodemographic characteristics was collected through maternal interviews
at baseline. Gestational age was determined by the physician using the date of the last
menstrual period. At each monthly visit, participants underwent physical examination and
anthropometric assessments. Study nurses recorded single values for systolic and diastolic
blood pressure at each visit with a mercury sphygmomanometer while participants were at
rest. Routine laboratory tests were conducted as described elsewhere [17].
Maternal complications included preterm delivery, severe preterm delivery, hypertension,
cesarean delivery, and severe anemia. All deliveries that occurred before 37 weeks of
gestation were considered preterm. Those that occurred before 34 weeks were considered
severely preterm. Hypertension was defined as a systolic blood pressure of 140 mm Hg or
more or a diastolic blood pressure of 90 mm Hg or more at any time during pregnancy.
Cesarean delivery was recorded by the research midwives who attended to participants
during labor.
Newborn growth parameters included birth weight, SGA status, crown–heel length, head
circumference, and placental weight. After delivery, research midwives weighed neonates
and placentas to the nearest 10 g and measured newborn length and head circumference to
the nearest 0.1 cm. Neonates weighing less than 2500 g were categorized as low birth
weight. Those weighing more than 4000 g were categorized as macrosomic. SGA status was
defined as a birth weight below the 10th percentile for gestational age. US standards were
used as the “reference population” because they might provide a better reflection of growth
potential unaffected by nutritional deprivation than local norms [17]. Fetal and perinatal
mortality outcomes included fetal loss (any death occurring before delivery), stillbirth
(deaths occurring at 28 gestational weeks or more), perinatal death (deaths that occurred
between 28 weeks of gestation and 1 week of delivery) and early infant deaths (deaths that
occurred before 6 weeks postpartum).
All statistical analyses were performed via SAS version 9.2 (SAS Institute, Cary, NC, USA).
Relative risks (RRs) and 95% confidence intervals (CIs) were determined by using
generalized estimating equations specified with the log-link function for all dichotomous
outcomes. In most cases, however, the log-binomial models failed to converge and were
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replaced with log-Poisson models, which provide consistent but not fully efficient estimates
of the RR and its CIs [20].
For models of hypertension in pregnancy, a compound symmetry working correlation matrix
was used to account for repeated measures of blood pressure [21]. Women with
hypertension at baseline were excluded from the analysis of this outcome. A compound
symmetry working correlation matrix was also specified for analyses of birth outcomes to
account for correlations due to twinning. Continuous endpoints were assessed with
generalized estimating equations with the use of the identity link and Gaussian variance
function and a compound symmetry working correlation matrix. Restricted cubic splines
[22] were used to model continuous glucose levels in relation to the outcomes of interest.
All analyses of birth outcomes were restricted to live births.
All multivariate models included age (<20 years, 20 to <25 years, 25 to <30 years, ≥30
years), nearest body mass index (BMI, calculated as weight in kilograms divided by the
square of height in meters) measurement prior to the time of glucose measurement (<18.5
kg/m2, 18.5–24.9 kg/m2, 25.0–29.9 kg/m2, ≥30.0 kg/m2), quartiles of nearest mid-upper arm
circumference prior to the time of glucose measurement, Filmer–Pritchett wealth score
below median (yes/no), and receipt of multivitamins (yes/no).
In addition, for each separate outcome, the following characteristics were considered to be
potential confounders if they predicted the outcome in univariate analysis at a P value of
0.20 or less: literacy (yes/no); marital status (yes/no); dependence on others for economic
support (yes/no); low daily per capita food expenditure (yes/no); education (0–4, 5–7, 8–11,
≥12 years); frequency of meat or fish intake (<1 per month, 1–3 times per month, about
once/week, 2–4 times per week, 5–7 times per week); gravidity (0, 1, ≥2); gestational age at
time of glucose measurement (<25 weeks, ≥25 weeks); weight gain from study entry to the
time of glucose measurement (<3 kg, 3 to <6 kg, 6 to <9 kg, ≥9 kg); quartiles of nearest
triceps skin fold thickness measurement prior to time of glucose measurement; nearest
hemoglobin measurement prior to time of glucose measurement (<8.5 g/L, 8.5–10.9 g/L,
≥11.0 g/dL); smoking (yes/no); year of recruitment (2001, 2002, 2003, 2004); district of
recruitment (Ilala, Temeke, Kinondoni); history of hypertension during the current
pregnancy (yes/no; for analysis of hypertension); family history of hypertension (yes/no; for
analysis of hypertension); family history of diabetes (yes/no); history of a low birth weight
newborn (yes/no; for analyses of fetal growth) history of fetal loss (yes/no; for analyses of
fetal and infant mortality); use of hematinics during this pregnancy (yes/no; for analyses of
hematologic outcomes). Missing indicators were used to retain observations in the analyses
for variables where more than 1% of total observations were missing [23]. Observations
containing missing values for model covariates with 1% or fewer total observations missing
were not retained in the analyses. A P value of less than 0.05 was considered to be
statistically significant.
3. Results
The original study population comprised 8468 pregnant women [17], of whom 3383 had
available glucose measurements and were included in the present analysis. Figure 1 shows
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derivation of the study population. Women with available glucose measurements (n=3383)
were comparable to those without glucose measurements (n=5045) with respect to baseline
characteristics (Table 1).
Of the 3383 participants included in the analysis, 25 (0.7%) had elevated glucose levels.
These participants were similar to those with normal glucose levels in terms of baseline
reproductive and socioeconomic characteristics at the time of enrollment into the larger trial
(Table 2). On average, participants with elevated glucose levels tended to be older and had
higher socio-economic status, higher BMI, and greater mid-upper arm circumference. A
substantially higher proportion of participants with elevated glucose had received the
multivitamin regimen during the trial.
Associations between maternal outcomes and glucose status are shown in Table 3. Women
with elevated glucose levels had a significantly and independently increased risk of preterm
delivery, severe preterm delivery, and incident gestational hypertension in multivariate
analyses. Risk of cesarean delivery seemed to increase at glucose values both above and
below normal levels (Figure 2; P value for nonlinearity, 0.01).
Elevated glucose also significantly increased the risk of low birth weight (Table 4). The
multivariate RR for low birth weight (<2500 kg) was 2.87 (95% CI, 1.18–6.99; P=0.02).
The relationship between continuous glucose levels and low birth weight deviated from
linearity (multivariate P value for nonlinearity, 0.03). When the outcome definition was
narrowed to low birth weight newborns who were born preterm, the association with
elevated glucose levels became stronger and remained borderline significant (multivariate
RR, 3.78; 95% CI, 1.01–14.19, P=0.05). However, the increased risk for low birth weight
term neonates among those with elevated glucose levels was nonsignificant (P=0.2). The
average head circumference of newborns of mothers with elevated glucose was 1.57 cm
smaller than that of newborns of mothers with normal glucose levels (95% CI, –2.51 to –
0.62; P=0.002) in multivariate analysis.
Continuous glucose levels had a nonlinear association with head circumference (multivariate
P value for nonlinearity, 0.05) and a positive association with crown–heel length
(multivariate OR, 0.27; 95% CI, 0.10–0.45). Women with elevated glucose levels were 3.38
times (95% CI, 1.13–10.08; P=0.03) more likely to experience fetal loss, and 3.58 (95% CI,
1.19–10.75; P=0.02) times more likely to experience stillbirth in particular (Table 5).
4. Discussion
The present results show that elevated glucose levels are rare among pregnant women in Dar
es Salaam, but nonetheless seem to strongly predict several adverse pregnancy outcomes,
including pre-term delivery, hypertension, low birth weight, decreased head circumference,
fetal loss, and stillbirth. They also suggest that crown–heel length increases with increasing
glucose levels, and the likelihood of a Cesarean delivery increases with both increasing and
decreasing glucose levels. These associations persisted even after adjustment for potential
confounders such as age, maternal anthropometry, socioeconomic status, and receipt of
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multivitamins, all of which differed between participants with normal and elevated glucose
levels.
Two studies in the early 1990s found no evidence of impaired glucose tolerance among
pregnant Tanzanian women [14,15]. The present results also suggest that elevated glucose
levels are rare among pregnant women in Dar es Salaam, although a conservative definition
of exposure was adopted because information was lacking on the timing of meal
consumption prior to the glucose test. Kileo [24] observed evidence of impaired glucose
tolerance among 11.1% of pregnant women who underwent random blood glucose testing at
Muhimbili National Hospital, Dar es Salaam, using a less conservative definition that
accounted for time since last meal. Those more recent data, which are similar to estimates
from elsewhere in sub-Saharan Africa [1,11–13], suggest that gestational hyperglycemia is
indeed a concern among Tanzanian pregnant women.
Direct comparison of the present findings with previous studies is limited by differences in
methods of glucose assessment. Nevertheless, the results do support past research suggesting
that elevated glucose levels below the threshold for overt diabetes are associated with
preterm birth [9], stillbirth [3], hypertension [10], and cesarean delivery [7]. The increased
risks for low birth weight and reduced head circumference observed among the study
women with elevated glucose levels suggest that maternal hyperglycemia may adversely
impact fetal growth in this population, although the significant increase in crown–heel
length seen with increasing glucose levels seems to contradict this supposition. Taken
together, these findings add to the abundance of data suggesting that glucose intolerance in
pregnancy has pathophysiologic consequences even before it progresses to overt diabetes. It
should be noted that these associations were noted in the present study despite the referral of
hyperglycemic participants for treatment as per standard of care. Untreated women in this
setting may have an even higher risk of these morbidities, given that treatment reduces the
risk of pregnancy complications.
The risk of cesarean delivery unexpectedly increased with decreasing glucose levels in the
present study. To our knowledge, such a finding has not previously been reported. We can
only speculate that reduced availability of maternal glucose may have contributed to fetal
growth restriction [25], leading to fetal distress during labor. Among the 22 participants who
delivered SGA neonates by cesarean, 17 had glucose levels of 3.1 mmol/L or lower.
The use of random blood glucose levels to measure hyperglycemia instead of a more
sensitive and specific test is a major limitation of the study. In addition, the low prevalence
of hyperglycemia limited the precision of the present estimates of RR. Furthermore, the use
of date of last menstrual period to determine gestational age may have resulted in some
misclassification of preterm deliveries. Any such misclassification would have occurred
independently of exposure status, however, and would lead to an underestimation of the RR.
Although the assessment of a large number of outcomes also increases the potential for
false-positive findings, the present outcome selection was hypothesis-driven and the results
largely concur with previous research. The strengths of the present study include the
prospective design and ability to control for a wide range of covariates as potential
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confounders. In addition, the similarity of participants with and without glucose
measurements was confirmed in support of the external validity of the findings.
In conclusion, the study found evidence of the well-established association between
abnormally elevated glucose levels and adverse pregnancy outcomes in urban Tanzania,
where many of these outcomes occur disproportionately. Larger studies using internationally
recommended screening procedures for gestational diabetes should confirm these findings
so that improvements in prenatal care for hyperglycemic women can be made in this setting.
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Figure 1.
Derivation of the study population.
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Figure 2.
Odds ratio of cesarean delivery by blood glucose levels. Broken lines represent 95% confidence intervals.
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Table 1
Comparison of baseline characteristics between women with glucose data available and those without a
Characteristic Glucose results available
(n=3383)
Glucose results unavailable
(n=5045)
Age, y 25.2 ± 5.0 25.1 ± 5.0
Literate 88 87
Completed secondary education 5 5
Married or cohabitating 89 88
Economically dependent on others 98 98
Low daily per capita expenditure on food 36 42
Filmer–Pritchett wealth score less than median 48 48
Nulliparous 47 45
Gestational age, wk 21.5 ± 3.3 21.0 ± 3.5
BMI 24.5 ± 3.6 24.6 ± 3.9
Mid-upper arm circumference, cm 26.3 ± 3.2 26.5 ± 3.3
Triceps skin fold thickness, mm 18.6 ± 6.5 19.0 ± 6.7
Received multivitamin regimen 51 49
Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by the square of height in meters).
aValues are given as mean ± SD or percentage.
Int J Gynaecol Obstet. Author manuscript; available in PMC 2015 April 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Darling et al. Page 12
Table 2
Baseline characteristics of women enrolled in the trial with available glucose levels (n=3383)
Characteristic Normal glucose levels
(n=3358)
Hyperglycemia or diabetes
(glucose >7.8 mmol/L)
(n=25)
Age, y 25.2 ± 5.1 26.65 ± 5.58
Literate 88 92
Married or cohabitating 89 100
Completed secondary education 5 2
Economically dependent on others 98 100
Low daily per capita expenditure on food 36 42
Filmer–Pritchett wealth score less than median 48 21
Nulliparous 47 58
Gestational age, wk 27.6 ± 3.8 27.1 ± 1.8
BMI 25.4 ± 3.8 27.8 ± 2.3
Mid-upper arm circumference, cm 26.4 ± 5.0 27.5 ± 1.5
Triceps skin fold thickness, mm 18.3 ± 6.5 18.2 ± 2.6
Received multivitamin regimen 51 34
Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by the square of height in meters).
aValues are given as mean ± SD or percentage.
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